search
Back to results

Effect of Pelvic Floor Stimulation on the Pelvic Floor Function in Cervical Cancer Patients With Type III Hysterectomy

Primary Purpose

Lower Urinary Tract Symptoms

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
PHENIX USB 8.
Sponsored by
Wang Jianliu
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Lower Urinary Tract Symptoms focused on measuring electrical stimulation, urinary incontinence

Eligibility Criteria

18 Years - 60 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients diagnosed as cervical squamous cell carcinoma on Ⅰa2, Ib1 or Ⅱa1 stage
  • Type III hysterectomy
  • There are pathological results showing that cancer resection clean and no distant metastasis,Specifically as follows:Lymph nodes(-);cancer foci invasion depth <1/2;Lymphatic space(-);Vaginal stump(-);differentiation G1-2.
  • Patients agreed to the study, informed consent

Exclusion Criteria:

  • Radiotherapy and chemotherapy before surgery
  • Reserved nerve in the surgery
  • Urinary system damage
  • POP(Pelvic Organ Prolapse stage)>II stage before surgery
  • Moderate above stress urinary incontinence(SUI) before surgery(1 hours urine pad test>=10g)
  • Urinary retention before surgery
  • Severe constipation or difficult defecation before surgery
  • There are uncontrolled epilepsy, central nervous system disease or mental disorder history in patients.The clinical severity of these diseases Influence clinical research compliance,judging by the researcher.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    Electric Stimulation Treatment

    control group

    Arm Description

    Patients in the intervention group were treated with electric stimulation based on the routine clinical nursing.

    patients in this group only received routine clinical nursing without electric stimulation

    Outcomes

    Primary Outcome Measures

    Urination function recovery rate

    Secondary Outcome Measures

    Number of participants with recovery of defecation function and urinary function after III hysterectomy
    Quality of life Questionnaire
    Overall Survival
    The overall survival (OS) in cervical cancer patients after 3 years' III hysterectomy after comparison of pelvic floor rehabilitation therapy and control group
    Disease-free survival
    Comparison of pelvic floor rehabilitation treatment group and control group of cervical cancer patients with type III hysterectomy 3 years disease-free survival (DFS)

    Full Information

    First Posted
    June 25, 2015
    Last Updated
    March 13, 2018
    Sponsor
    Wang Jianliu
    Collaborators
    Peking University, Peking University First Hospital, Peking University Third Hospital, Beijing Hospital, Chinese PLA General Hospital, Peking University Cancer Hospital & Institute, Chinese Academy of Medical Sciences, Beijing Obstetrics and Gynecology Hospital, Beijing Chao Yang Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02492542
    Brief Title
    Effect of Pelvic Floor Stimulation on the Pelvic Floor Function in Cervical Cancer Patients With Type III Hysterectomy
    Official Title
    Effect of Pelvic Floor Stimulation on the Pelvic Floor Function in Cervical Cancer Patients With Type III Hysterectomy
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2018
    Overall Recruitment Status
    Unknown status
    Study Start Date
    April 2015 (undefined)
    Primary Completion Date
    December 2018 (Anticipated)
    Study Completion Date
    December 2019 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    Wang Jianliu
    Collaborators
    Peking University, Peking University First Hospital, Peking University Third Hospital, Beijing Hospital, Chinese PLA General Hospital, Peking University Cancer Hospital & Institute, Chinese Academy of Medical Sciences, Beijing Obstetrics and Gynecology Hospital, Beijing Chao Yang Hospital

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The purpose of this study is to investigate the effect of electric stimulation on the pelvic floor function in cervical cancer patients with type III hysterectomy.
    Detailed Description
    This is a prospective, multi center, open, randomized, controlled clinical trial. All cervical carcinoma patients who undergo type III hysterectomy in the hospitals involved in this study were recruited. 5-7 days postoperative, those who meet the inclusion criteria and without the exclusion criteria and sign the consent were randomized grouped of intervention and control objective by 1:1. At the same time, according to the research hospital, menopausal status (menopause vs menopause) and surgery approach (laparoscopic vs open),they were further stratified randomly. Patients in the intervention group received electrical stimulation treatment based on conventional clinical nursing, while patients in control group only receive routine clinical care. Except for the treatment of electrical stimulation, other research procedures is the same in the two groups. The recovery rate of urination function, pelvic floor function and life quality of the two group is compared.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Lower Urinary Tract Symptoms
    Keywords
    electrical stimulation, urinary incontinence

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    208 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Electric Stimulation Treatment
    Arm Type
    Experimental
    Arm Description
    Patients in the intervention group were treated with electric stimulation based on the routine clinical nursing.
    Arm Title
    control group
    Arm Type
    No Intervention
    Arm Description
    patients in this group only received routine clinical nursing without electric stimulation
    Intervention Type
    Device
    Intervention Name(s)
    PHENIX USB 8.
    Other Intervention Name(s)
    Electric Stimulation Treatment
    Intervention Description
    Electrical stimulation program: frequency: 1/4/Hertz (HZ), pulse width: 270/230/270 μs, time: 30min. Electrode piece: 50*50mm sticky electrode plate. Position: an electrode piece is placed in the S3, and an electrode piece is placed in the bladder region.Current intensity adjusted according to the patient's tolerance, the maximum current intensity of the pain was not appropriate, generally not more than 100milliampere(mA).Devices PHENIX USB 8.
    Primary Outcome Measure Information:
    Title
    Urination function recovery rate
    Time Frame
    From 14 days to 24 months after operation
    Secondary Outcome Measure Information:
    Title
    Number of participants with recovery of defecation function and urinary function after III hysterectomy
    Time Frame
    From 14 days to 24 months after operation
    Title
    Quality of life Questionnaire
    Time Frame
    From 14 days to 24 months after operation
    Title
    Overall Survival
    Description
    The overall survival (OS) in cervical cancer patients after 3 years' III hysterectomy after comparison of pelvic floor rehabilitation therapy and control group
    Time Frame
    From 14 days to 24 months after operation
    Title
    Disease-free survival
    Description
    Comparison of pelvic floor rehabilitation treatment group and control group of cervical cancer patients with type III hysterectomy 3 years disease-free survival (DFS)
    Time Frame
    From 14 days to 24 months after operation

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    60 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients diagnosed as cervical squamous cell carcinoma on Ⅰa2, Ib1 or Ⅱa1 stage Type III hysterectomy There are pathological results showing that cancer resection clean and no distant metastasis,Specifically as follows:Lymph nodes(-);cancer foci invasion depth <1/2;Lymphatic space(-);Vaginal stump(-);differentiation G1-2. Patients agreed to the study, informed consent Exclusion Criteria: Radiotherapy and chemotherapy before surgery Reserved nerve in the surgery Urinary system damage POP(Pelvic Organ Prolapse stage)>II stage before surgery Moderate above stress urinary incontinence(SUI) before surgery(1 hours urine pad test>=10g) Urinary retention before surgery Severe constipation or difficult defecation before surgery There are uncontrolled epilepsy, central nervous system disease or mental disorder history in patients.The clinical severity of these diseases Influence clinical research compliance,judging by the researcher.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Wang J liu, Doctor
    Organizational Affiliation
    Peking University People's Hospital Ob and Gy
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    21277788
    Citation
    Plotti F, Angioli R, Zullo MA, Sansone M, Altavilla T, Antonelli E, Montera R, Damiani P, Benedetti Panici P. Update on urodynamic bladder dysfunctions after radical hysterectomy for cervical cancer. Crit Rev Oncol Hematol. 2011 Nov;80(2):323-9. doi: 10.1016/j.critrevonc.2010.12.004. Epub 2011 Jan 31.
    Results Reference
    result
    PubMed Identifier
    9299255
    Citation
    Griffenberg L, Morris M, Atkinson N, Levenback C. The effect of dietary fiber on bowel function following radical hysterectomy: a randomized trial. Gynecol Oncol. 1997 Sep;66(3):417-24. doi: 10.1006/gyno.1997.4797.
    Results Reference
    result
    PubMed Identifier
    16445968
    Citation
    Raspagliesi F, Ditto A, Fontanelli R, Zanaboni F, Solima E, Spatti G, Hanozet F, Vecchione F, Rossi G, Kusamura S. Type II versus Type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions. Gynecol Oncol. 2006 Aug;102(2):256-62. doi: 10.1016/j.ygyno.2005.12.014. Epub 2006 Jan 30.
    Results Reference
    result
    PubMed Identifier
    16445658
    Citation
    Jackson KS, Naik R. Pelvic floor dysfunction and radical hysterectomy. Int J Gynecol Cancer. 2006 Jan-Feb;16(1):354-63. doi: 10.1111/j.1525-1438.2006.00347.x.
    Results Reference
    result
    PubMed Identifier
    12375757
    Citation
    Sood AK, Nygaard I, Shahin MS, Sorosky JI, Lutgendorf SK, Rao SS. Anorectal dysfunction after surgical treatment for cervical cancer. J Am Coll Surg. 2002 Oct;195(4):513-9. doi: 10.1016/s1072-7515(02)01311-x.
    Results Reference
    result
    PubMed Identifier
    16516431
    Citation
    Axelsen SM, Petersen LK. Urogynaecological dysfunction after radical hysterectomy. Eur J Surg Oncol. 2006 May;32(4):445-9. doi: 10.1016/j.ejso.2006.01.017. Epub 2006 Mar 3.
    Results Reference
    result
    PubMed Identifier
    15512265
    Citation
    Butler-Manuel SA, Summerville K, Ford A, Blake P, Riley AJ, Sultan AH, Monga AK, Stanton SL, Shepherd JH, Barton DP. Self-assessment of morbidity following radical hysterectomy for cervical cancer. J Obstet Gynaecol. 1999 Mar;19(2):180-3. doi: 10.1080/01443619965552.
    Results Reference
    result
    PubMed Identifier
    19374292
    Citation
    Manchana T, Sirisabya N, Lertkhachonsuk R, Worasethsin P, Khemapech N, Sittisomwong T, Vasuratna A, Termrungruanglert W, Tresukosol D. Long term complications after radical hysterectomy with pelvic lymphadenectomy. J Med Assoc Thai. 2009 Apr;92(4):451-6.
    Results Reference
    result
    PubMed Identifier
    20571765
    Citation
    Sansone M, Plotti F, Panici PB. Long-term lower urinary tract dysfunction after radical hysterectomy in patients with early postoperative voiding dysfunction. Int Urogynecol J. 2010 Oct;21(10):1309-10; author reply 1311-2. doi: 10.1007/s00192-010-1206-1. Epub 2010 Jun 23. No abstract available.
    Results Reference
    result
    PubMed Identifier
    1894168
    Citation
    Barnes W, Waggoner S, Delgado G, Maher K, Potkul R, Barter J, Benjamin S. Manometric characterization of rectal dysfunction following radical hysterectomy. Gynecol Oncol. 1991 Aug;42(2):116-9. doi: 10.1016/0090-8258(91)90329-4.
    Results Reference
    result
    PubMed Identifier
    25033255
    Citation
    Ye S, Yang J, Cao D, Lang J, Shen K. A systematic review of quality of life and sexual function of patients with cervical cancer after treatment. Int J Gynecol Cancer. 2014 Sep;24(7):1146-57. doi: 10.1097/IGC.0000000000000207.
    Results Reference
    result
    PubMed Identifier
    19748761
    Citation
    Maddocks M, Lewis M, Chauhan A, Manderson C, Hocknell J, Wilcock A. Randomized controlled pilot study of neuromuscular electrical stimulation of the quadriceps in patients with non-small cell lung cancer. J Pain Symptom Manage. 2009 Dec;38(6):950-6. doi: 10.1016/j.jpainsymman.2009.05.011.
    Results Reference
    result
    PubMed Identifier
    19853518
    Citation
    Bennett MI, Johnson MI, Brown SR, Radford H, Brown JM, Searle RD. Feasibility study of Transcutaneous Electrical Nerve Stimulation (TENS) for cancer bone pain. J Pain. 2010 Apr;11(4):351-9. doi: 10.1016/j.jpain.2009.08.002. Epub 2009 Oct 22.
    Results Reference
    result
    PubMed Identifier
    18790600
    Citation
    Robb K, Oxberry SG, Bennett MI, Johnson MI, Simpson KH, Searle RD. A cochrane systematic review of transcutaneous electrical nerve stimulation for cancer pain. J Pain Symptom Manage. 2009 Apr;37(4):746-53. doi: 10.1016/j.jpainsymman.2008.03.022. Epub 2008 Sep 14.
    Results Reference
    result
    PubMed Identifier
    22472463
    Citation
    Yang EJ, Lim JY, Rah UW, Kim YB. Effect of a pelvic floor muscle training program on gynecologic cancer survivors with pelvic floor dysfunction: a randomized controlled trial. Gynecol Oncol. 2012 Jun;125(3):705-11. doi: 10.1016/j.ygyno.2012.03.045. Epub 2012 Apr 1.
    Results Reference
    result
    PubMed Identifier
    19095492
    Citation
    Ryu JS, Kang JY, Park JY, Nam SY, Choi SH, Roh JL, Kim SY, Choi KH. The effect of electrical stimulation therapy on dysphagia following treatment for head and neck cancer. Oral Oncol. 2009 Aug;45(8):665-8. doi: 10.1016/j.oraloncology.2008.10.005. Epub 2008 Dec 17.
    Results Reference
    result
    PubMed Identifier
    34713337
    Citation
    Wang S, Gao L, Wen H, Gao Y, Lv Q, Li H, Wang S, Wang Y, Liu Q, Han J, Wang H, Li Y, Yu N, Wang Q, Cao T, Wang S, Sun H, Wang Z, Sun X, Wang J. Evaluation of pelvic floor muscle function (PFMF) in cervical cancer patients with Querleu-Morrow type C hysterectomy: a multicenter study. Arch Gynecol Obstet. 2022 Feb;305(2):397-406. doi: 10.1007/s00404-021-06290-6. Epub 2021 Oct 28.
    Results Reference
    derived
    PubMed Identifier
    34660617
    Citation
    Li XW, Gao L, Wang Q, Lv QB, Xia ZJ, Wen HW, Han JS, Wu YM, Wang SM, Liu Q, Li H, Wang HB, Li Y, Wang SY, Wang ZQ, Sun XL, Wang JL. Long-Term Effect of Early Post-operative Transcutaneous Electrical Stimulation on Voiding Function After Radical Hysterectomy: A Multicenter, Randomized, Controlled Trial. Front Med (Lausanne). 2021 Sep 30;8:677029. doi: 10.3389/fmed.2021.677029. eCollection 2021.
    Results Reference
    derived
    PubMed Identifier
    28619043
    Citation
    Sun XL, Wang HB, Wang ZQ, Cao TT, Yang X, Han JS, Wu YF, Reilly KH, Wang JL. Effect of transcutaneous electrical stimulation treatment on lower urinary tract symptoms after class III radical hysterectomy in cervical cancer patients: study protocol for a multicentre, randomized controlled trial. BMC Cancer. 2017 Jun 15;17(1):416. doi: 10.1186/s12885-017-3387-1.
    Results Reference
    derived

    Learn more about this trial

    Effect of Pelvic Floor Stimulation on the Pelvic Floor Function in Cervical Cancer Patients With Type III Hysterectomy

    We'll reach out to this number within 24 hrs